查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566758

玻璃體視網膜手術器械市場：依產品類型、手術類型、最終用戶：2024-2033 年全球機會分析與產業預測

Vitreoretinal Surgery Devices Market By Product , By Surgery Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

玻璃體視網膜手術裝置

2023年玻璃體視網膜手術器械市值為23億美元，預計2024年至2033年複合年成長率為5.9%，到2033年達到41億美元。

玻璃體視網膜手術設備是一種專門設備，對於進行針對眼睛視網膜和玻璃體的眼科手術至關重要。使用這些設備可以治療多種視網膜疾病，例如黃斑裂孔、視網膜剝離、糖尿病視網膜病變和視網膜前膜，以修復和恢復眼睛的正常解剖結構和功能。設備創新可實現微創手術，進而縮短恢復時間並改善患者的治療效果。

眼科手術的普及，特別是在老年族群中，是玻璃體視網膜手術設備市場的關鍵促進因素。此外，政府在醫療保健設施上的支出增加導致玻璃體視網膜手術設備的進步，支持其在醫療實踐中的採用。目前，將機器人技術整合到手術設備中是市場的新趨勢。在如此複雜的手術中，這項技術優於人類技術，減少了出錯的機會並提高了精確度。研究人員的目標是透過結合機器人技術和人工智慧來實現智慧手術。

然而，採購玻璃體視網膜手術設備的高昂初始成本和維護要求阻礙了小型醫療機構的投資。這限制了各個新興國家和服務欠缺地區的市場成長。相較之下，眼科疾病的數量不斷增加，預計未來將推動玻璃體視網膜手術設備的採用。根據 Bright Focus 基金會 2022 年 10 月發布的情況說明書，美國約有 1,100 萬人患有某種形式的老齡化黃斑部病變。該基金會預測，到 2050 年，這一數字將加倍，達到近 2,200 萬，迫使人們使用治療設備。

板塊回顧

玻璃體視網膜手術器械市場分為產品、手術類型、最終用戶和地區。依產品，市場分為全氟化碳流體、內部照明裝置、玻璃體視網膜預填充矽膠注射器、玻璃體切除系統等。根據手術類型，市場分為前部視網膜玻璃體手術和後部視網膜玻璃體手術。依最終用戶分類，可分為醫院、專科診所和門診手術中心。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

從產品來看，玻璃體切割系統細分市場將在 2023 年佔據主導地位。

按手術類型分類，前視網膜玻璃體手術細分市場在 2023 年佔據了較高的市場佔有率。

按最終用戶分類，醫院細分市場在 2023 年佔據最高市場佔有率。

按地區分類，北美地區 2023 年收益最高。

該報告可以客製化。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料
  • 主要參與企業的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章玻璃體視網膜手術器械市場：依產品

  • 市場概況
  • 全氟化碳液
  • 內部照明設備
  • 玻璃體視網膜預填充矽膠注射器
  • 玻璃體切除系統
  • 其他

第5章玻璃體視網膜手術器械市場：依手術類型

  • 市場概況
  • 前視網膜玻璃體手術
  • 視網膜後玻璃體手術

第6章玻璃體視網膜手術器械市場：依最終用戶分類

  • 市場概況
  • 醫院
  • 專科診所
  • 門診手術中心

第7章血管手術器械市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國玻璃體視網膜手術器械市場
    • 加拿大玻璃體視網膜手術設備市場
    • 墨西哥玻璃體視網膜手術器械市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國玻璃體視網膜手術器械市場
    • 法國玻璃體視網膜手術器械市場
    • 英國玻璃體視網膜手術器械市場
    • 義大利玻璃體視網膜手術器械市場
    • 西班牙玻璃體視網膜手術器械市場
    • 其他歐洲玻璃體視網膜手術器械市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本玻璃體視網膜手術器械市場
    • 中國玻璃體視網膜手術器械市場
    • 澳洲玻璃體視網膜手術器械市場
    • 印度玻璃體視網膜手術器械市場
    • 韓國玻璃體視網膜手術器械市場
    • 其他亞太玻璃體視網膜手術器械市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西玻璃體視網膜手術器械市場
    • 沙烏地阿拉伯的玻璃體視網膜手術設備市場
    • 南非玻璃體視網膜手術器械市場
    • 其他拉丁美洲/中東/非洲玻璃體視網膜手術設備市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Bausch And Lomb
  • Novartis AG
  • Inami And Co
  • Paragon Care Group Pty Ltd
  • Oculus Inc
  • MedOne Surgical, Inc
  • Carl Zeiss Meditec AG
  • Peregrine Surgical
  • Johnson And Johnson
  • Blink Medical
簡介目錄
Product Code: A00914

Vitreoretinal Surgery Devices

The vitreoretinal surgery devices market was valued at $2.3 billion in 2023 and is projected to reach $4.1 billion by 2033, growing at a CAGR of 5.9% from 2024 to 2033.

Vitreoretinal surgery devices are the specialized equipment essential to perform ophthalmic surgeries focused on retina and vitreous humor of eyes. Diverse retinal conditions such as macular holes, retinal detachments, diabetic retinopathy, and epiretinal membranes are treated using these devices for the repair & restoration of the normal anatomy and function of the eyes. Innovations in devices allow surgeries to be performed with minimal invasion, hence lowering the recovery times and improving patient outcomes.

Increase in the prevalence of eye surgeries, particularly among the old generation, is a key driver of the vitreoretinal surgery devices market. In addition, rise in expenditure by the government toward healthcare facilities has led to advancements in the vitreoretinal surgery devices, which is boosting their adoption in the healthcare settings. Currently, the integration of robotics technology into surgery devices is an emerging trend in the market. The technology exceeds human skills in such complex surgeries, reducing the possibility of errors and enhancing the precision. The researchers aim to create smart surgery procedures by the assimilation of robotics and AI.

However, the high upfront costs of procuring the vitreoretinal surgery devices, along with their maintenance requirements deters various small-scale healthcare facilities from investing in them. This restrains the market growth in various developing and underserved regions. Contrarily, the constantly rising numbers of eye conditions are projected to boost the adoption of vitreoretinal surgery devices in the future. According to a factsheet released by Bright Focus Foundation on October 2022, approximately 11 million individuals in the U.S. suffer from some form of age-related macular degeneration. The foundation anticipates the number to double to nearly 22 million by 2050, hence compelling the use of the devices for treatment.

Segment Review

The vitreoretinal surgery devices market is segmented into product, surgery type, end user, and region. On the basis of product, the market is divided into perfluorocarbon liquids, endoillumination instrument, vitreoretinal prefilled silicone oil syringes, vitrectomy system, and other. Depending on surgery type, the market is bifurcated into anterior vitreoretinal surgery and posterior vitreoretinal surgery. As per end user, it is categorized into hospitals, specialty clinics, and ambulatory surgery centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the vitrectomy system segment dominated the market in 2023.

Depending on surgery type, the anterior vitreoretinal surgery segment acquired a high stake at the market in 2023.

As per end user, the hospitals segment accounted for a high market share in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global vitreoretinal surgery devices market include Bausch & Lomb, Novartis AG, Inami & Co, Paragon Care Group Pty Ltd, Oculus Inc, MedOne Surgical, Inc, Carl Zeiss Meditec AG, Peregrine Surgical, Johnson & Johnson, and Blink Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Perfluorocarbon Liquids
  • Endoillumination Instrument
  • Vitreoretinal Prefilled Silicone Oil Syringes
  • Vitrectomy System
  • Other

By Surgery Type

  • Anterior Vitreoretinal Surgery
  • Posterior Vitreoretinal Surgery

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Bausch & Lomb
    • Novartis AG
    • Inami & Co
    • Paragon Care Group Pty Ltd
    • Oculus Inc
    • MedOne Surgical, Inc
    • Carl Zeiss Meditec AG
    • Peregrine Surgical
    • Johnson & Johnson
    • Blink Medical

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: VITREORETINAL SURGERY DEVICES MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Perfluorocarbon Liquids
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Endoillumination Instrument
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Vitreoretinal Prefilled Silicone Oil Syringes
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Vitrectomy System
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Other
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: VITREORETINAL SURGERY DEVICES MARKET, BY SURGERY TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Surgery Type
  • 5.2. Anterior Vitreoretinal Surgery
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Posterior Vitreoretinal Surgery
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: VITREORETINAL SURGERY DEVICES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Specialty Clinics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Ambulatory Surgery Centers
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: VITREORETINAL SURGERY DEVICES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Surgery Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Vitreoretinal Surgery Devices Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Surgery Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Vitreoretinal Surgery Devices Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Surgery Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Vitreoretinal Surgery Devices Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Surgery Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Surgery Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Vitreoretinal Surgery Devices Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Surgery Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Vitreoretinal Surgery Devices Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Surgery Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Vitreoretinal Surgery Devices Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Surgery Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Vitreoretinal Surgery Devices Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Surgery Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Vitreoretinal Surgery Devices Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Surgery Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Vitreoretinal Surgery Devices Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Surgery Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Surgery Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Vitreoretinal Surgery Devices Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Surgery Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Vitreoretinal Surgery Devices Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Surgery Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. Australia Vitreoretinal Surgery Devices Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Surgery Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. India Vitreoretinal Surgery Devices Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Surgery Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Vitreoretinal Surgery Devices Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Surgery Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Vitreoretinal Surgery Devices Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Surgery Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Surgery Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Vitreoretinal Surgery Devices Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Surgery Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Vitreoretinal Surgery Devices Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Surgery Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Vitreoretinal Surgery Devices Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Surgery Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Vitreoretinal Surgery Devices Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Surgery Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Bausch And Lomb
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Novartis AG
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Inami And Co
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Paragon Care Group Pty Ltd
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Oculus Inc
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. MedOne Surgical, Inc
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Carl Zeiss Meditec AG
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Peregrine Surgical
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Johnson And Johnson
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Blink Medical
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments